Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

598
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
598
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

502
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
502
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.4K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

388
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
388
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing the in vitro architecture of human disease.

Disease models & mechanisms·2026
Same author

Evaluating large language models on multilingual vaccine knowledge: a benchmark study.

NPJ vaccines·2026
Same author

Prediction of hospitalisation in young children with pneumonia in Malawi: A machine learning-based approach.

PLoS medicine·2026
Same author

CES1 deficiency is associated with metabolic reprograming and endothelial dysfunction in pulmonary arterial hypertension.

American journal of respiratory and critical care medicine·2026
Same author

Telomere shortening in laminopathic dilated cardiomyopathy.

NPJ Regenerative medicine·2026
Same author

Somatic PIK3CA Activating Mutation in a Plexiform Lesion of a Patient With HHT and PAH.

JACC. Case reports·2026

Related Experiment Video

Updated: Apr 28, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

7.4K

An Adaptive Staggered Dose Design for a Normal Endpoint.

Joseph Wu1, Sandeep Menon, Mark Chang

  • 1a Department of Biostatistics , Boston University School of Public Health , Boston , Massachusetts , USA.

Journal of Biopharmaceutical Statistics
|June 7, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces an adaptive staggered dose design for clinical trials, improving efficiency by prioritizing doses based on prior information. The new method enhances statistical power compared to traditional drop-the-losers designs.

Keywords:
Adaptive designDose responseDose selectionError spending functionsGroup sequentialStaggered dose design

More Related Videos

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.0K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Related Experiment Videos

Last Updated: Apr 28, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

7.4K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.0K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • Pharmacometrics

Background:

  • Multi-stage clinical trial designs aim to efficiently select and confirm optimal doses.
  • Existing methods like drop-the-losers designs often lack dose prioritization based on prior response data.
  • This limits trial efficiency when dose-response information is available.

Purpose of the Study:

  • To propose a novel adaptive staggered dose procedure for clinical trials.
  • To incorporate dose prioritization and error spending schemes favoring promising doses.
  • To enhance statistical power and trial efficiency using existing dose-response information.

Main Methods:

  • Developed an adaptive staggered dose procedure starting with a subset of doses.
  • Implemented an error spending scheme to prioritize doses with assumed better responses.
  • Utilized simulations to compare the proposed design with the drop-the-losers design.

Main Results:

  • The proposed adaptive staggered dose design demonstrated improved statistical power.
  • Performance gains were observed particularly when strong prior information on dose response was available.
  • The design allows for adaptive addition of doses based on interim results.

Conclusions:

  • The adaptive staggered dose procedure offers a more efficient approach to dose selection and confirmation in clinical trials.
  • Prioritizing doses based on existing information significantly enhances statistical power.
  • This design represents an advancement over traditional methods, especially in trials with known dose-response trends.